½ÃÀ庸°í¼­
»óǰÄÚµå
1166231

¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀå Á¶»ç ¸®Æ÷Æ® - ¾÷°è ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2022-2028³â)

Global Atrial Fibrillation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 85 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Value Market Research»ç´Â ¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀåÀ» ½Éµµ ÀÖ°Ô Á¶»çÇßÀ¸¸ç, ÇâÈÄ ¸î ³â°£ ¾÷°èÀÇ ±Þ¼ºÀåÀ» ¿¹°ßÇϰí ÀÖ½À´Ï´Ù. ¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ¸®Æ÷Æ®¿¡¼­´Â ¿ÏÀüÇÑ »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¼ºÀå µ¿Çâ, 2023-2028³â°£ ¿¹Ãø µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. »ó¼¼ÇÑ ½ÃÀå ¼­·Ð°ú º¸°í¼­ÀÇ ÁÖ¿ä ¼ºÀå ¼öÄ¡¿¡ ÇÏÀ̶óÀÌÆ®¸¦ ¸ÂÃá ÁÖ¿ä ¿ä¾à¿¡¼­ ½ÃÀ۵˴ϴÙ. °è¼ÓµÇ´Â Àå¿¡¼­´Â ½ÃÀå ¹ë·ùüÀÎ, Porter's Five Forces ¸ðµ¨, ½ÃÀåÀÇ ¸Å·Âµµ¿¡ ´ëÇØ ³íÇß½À´Ï´Ù. ¶ÇÇÑ COVID-19ÀÇ ¿µÇ⠺м®¿¡ °üÇÑ µ¶ÀÚÀûÀÎ ÀåÀ» ¸¶·ÃÇÏ¿© ½ÃÀåÀÌ ÆÒµ¥¹Í¿¡ ¾î¶»°Ô ´ëÀÀÇØ ¿Ô´ÂÁö¿¡ ´ëÇØ ÀÌÇØÇÒ ¼ö ÀÖ´Â Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

  • º» º¸°í¼­ÀÇ ³»¿ë
    • ¸ñÀû
    • ´ë»ó µ¶ÀÚ
    • USP(Unique Selling Proposition)°ú Á¦°ø Á¦Ç°
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • ½ÃÀå Á¶»ç °úÁ¤
    • ½ÃÀå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½É¹æ¼¼µ¿ ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ÇöȲ

Á¦3Àå ½É¹æ¼¼µ¿ : »ê¾÷ ºÐ¼®

  • ¼­·Ð
  • ½É¹æ¼¼µ¿ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½É¹æ¼¼µ¿ ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½É¹æ¼¼µ¿ ½ÃÀå ±âȸ
  • ½É¹æ¼¼µ¿ ½ÃÀå µ¿Çâ
  • ½É¹æ¼¼µ¿ ½ÃÀå Porter's Five Forces ºÐ¼®
  • ½É¹æ¼¼µ¿ ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
    • À¯Çüº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
    • Áö¿ªº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ½É¹æ¼¼µ¿ ¹ë·ùüÀÎ ºÐ¼®
  • ½É¹æ¼¼µ¿ ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ½É¹æ¼¼µ¿ ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ½É¹æ¼¼µ¿ ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
  • ÀáÀçÀûÀÎ ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³ÎÀÇ ½ÅÈï ±¹°¡ ½ÃÀå °³Ã´ µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ºÐ¼® : À¯Çüº°

  • À¯Çüº° °³¿ä
  • ¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀå À¯Çüº° ºÐ¼®
  • ¿Ü°ú ¼ö¼ú : Áö¿ªº° ½ÃÀå ºÐ¼®
  • ºñ¿Ü°ú ¼ö¼ú : Áö¿ªº° ½ÃÀå ºÐ¼®

Á¦6Àå ¼¼°èÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ºÐ¼® : Áö¿ªº° °³¿ä

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹Ì
    • °³¿ä
    • ºÏ¹ÌÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ¿¹Ãø : ½ÃÀå ºÎ¹®º°
    • ºÏ¹ÌÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ¿¹Ãø : ±¹°¡º°
    • ¹Ì±¹
    • ±âŸ ºÏ¹Ì
  • À¯·´
    • °³¿ä
    • À¯·´ÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ¿¹Ãø : ½ÃÀå ºÎ¹®º°
    • À¯·´ÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ¿¹Ãø : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • °³¿ä
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ¿¹Ãø : ½ÃÀå ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ¿¹Ãø : ±¹°¡º°
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • °³¿ä
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ¿¹Ãø : ½ÃÀå ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ¿¹Ãø : ±¹°¡º°
    • ºê¶óÁú
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • °³¿ä
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ¿¹Ãø : ½ÃÀå ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½É¹æ¼¼µ¿ ½ÃÀå ¿¹Ãø : ±¹°¡º°
    • Áßµ¿ Áö¿ª
    • ¾ÆÇÁ¸®Ä«

Á¦7Àå ½É¹æ¼¼µ¿ °ü·Ã ±â¾÷ °æÀï ±¸µµ

  • ½É¹æ¼¼µ¿ ½ÃÀå °æÀï ±¸µµ
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ
  • ÀμöÇÕº´(M&A)
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦8Àå ±â¾÷ °³¿ä

  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Abbott Laboratories
    • ±â¾÷ °³¿ä
    • Á¦Ç° ¼Ò°³
    • ÃÖ±Ù °³¹ß »óȲ
  • Atricure, Inc.
    • ±â¾÷ °³¿ä
    • Á¦Ç° ¼Ò°³
    • ÃÖ±Ù °³¹ß »óȲ
  • Biotronik Se & Co. Kg
    • ±â¾÷ °³¿ä
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Boston Scientific Corporation
    • ±â¾÷ °³¿ä
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Johnson & Johnson
    • ±â¾÷ °³¿ä
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Koninklijke Philips N.V.
    • ±â¾÷ °³¿ä
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Medtronic Plc
    • ±â¾÷ °³¿ä
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Microport Scientific Corporation
    • ±â¾÷ °³¿ä
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Siemens Ag
    • ±â¾÷ °³¿ä
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • St. Jude Medical Inc.
    • ±â¾÷ °³¿ä
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ

Á¦9Àå COVID-19 ¹ß»ý¿¡ ÀÇÇÑ ¿µÇ⠺м®

  • COVID-19 ¹ß»ýÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇ⠺м®
    • »ý»ê¿¡ ´ëÇÑ Á÷Á¢ÀûÀÎ ¿µÇâ
    • °ø±Þ¸Á°ú ½ÃÀå È¥¶õ
    • ±â¾÷ ¹× ±ÝÀ¶ ½ÃÀå¿¡ ´ëÇÑ À繫Àû ¿µÇâ
  • COVID-19ÀÇ »ý»ê/¼öÀÔ/¼öÃâ/¼ö¿ä¿¡ ´ëÇÑ ¿µÇ⠺м®
  • COVID-19 ¹ß»ý ÀüÈÄ ½ÃÀå ÃßÀÌ
  • Äڷγª¹ÙÀÌ·¯½º(COVID-19) À¯ÇàÀÇ 2020³â ½ÃÀå ±Ô¸ð¿¡ ´ëÇÑ ¿µÇâ ¿¹Ãø : ½Ã³ª¸®¿Àº°
  • COVID-19 : ½ÃÀå¿¡ °üÇÑ ¹Ì½ÃÀû ¹× °Å½ÃÀû ¿äÀÎ ºÐ¼®

ÁÖ : ±â¾÷ °³¿ä¿¡¼­ À繫 ³»¿ëÀ̳ª ÃÖ±Ù °³¹ß »óȲÀº ÀÔ¼ö °¡´ÉÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ °ÍÀ̸ç, ºñ°ø°³ ȸ»çÀÇ °æ¿ì´Â °ÔÀçµÇ¾î ÀÖÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù.

LSH 22.12.09

Value Market Research deeply researched the Global Atrial Fibrillation Market to foresee a significant growth in the industry over the upcoming years. The global atrial fibrillation market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global atrial fibrillation market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this atrial fibrillation market.

The next sections of the atrial fibrillation market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Type

Surgical

MAZE Surgery

Catheter Ablation

Non-Surgical

Electric Cardioversion

Mapping & Recording System

Cardiac Monitors

Access Devices

Left Atrial Appendage (LAA) And Closure Device

Intracardiac Echocardiography (ICE) system

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Atrial Fibrillation Market
  • 2.2. Global Atrial Fibrillation Market Snapshot

3 . ATRIAL FIBRILLATION - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Atrial Fibrillation Market
  • 3.3. Market Restraints of Atrial Fibrillation Market
  • 3.4. Opportunities of Atrial Fibrillation Market
  • 3.5. Trends of Atrial Fibrillation Market
  • 3.6. Porter's Five Force Analysis of Atrial Fibrillation Market
  • 3.7. Atrial Fibrillation Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Type
    • 3.7.2 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Atrial Fibrillation Value Chain Analysis
  • 4.2. Atrial Fibrillation Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Atrial Fibrillation Raw Material Manufactures List
    • 4.2.3. Price Trend of Atrial Fibrillation Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ATRIAL FIBRILLATION MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Global Atrial Fibrillation Market Analysis by Type
  • 5.3 Market Analysis of Surgical by Regions
  • 5.4 Market Analysis of Non-Surgical by Regions

6 . GLOBAL ATRIAL FIBRILLATION MARKET ANALYSIS BY GEOGRAPHY

  • 6.1. Regional Outlook
  • 6.2. Introduction
  • 6.3. North America
    • 6.3.1. Overview
    • 6.3.2. North America Atrial Fibrillation Market Estimate by Market Segment
    • 6.3.3. North America Atrial Fibrillation Market Estimate by Country
    • 6.3.4. United State
    • 6.3.5. Rest of North America
  • 6.4. Europe
    • 6.4.1. Overview
    • 6.4.2. Europe Atrial Fibrillation Market Estimate by Market Segment
    • 6.4.3. Europe Atrial Fibrillation Market Estimate by Country
    • 6.4.4. United Kingdom
    • 6.4.5. France
    • 6.4.6. Germany
    • 6.4.6 Rest of Europe
  • 6.5. Asia Pacific
    • 6.5.1. Overview
    • 6.5.2. Asia Pacific Atrial Fibrillation Market Estimate by Market Segment
    • 6.5.3. Asia Pacific Atrial Fibrillation Market Estimate by Country
    • 6.5.4. China
    • 6.5.5. Japan
    • 6.5.6. India
    • 6.5.6. Rest of Asia Pacific
  • 6.6. Latin America
    • 6.6.1. Overview
    • 6.6.2. Latin America Atrial Fibrillation Market Estimate by Market Segment
    • 6.6.3. Latin America Atrial Fibrillation Market Estimate by Country
    • 6.6.4. Brazil
    • 6.6.5. Rest of Latin America
  • 6.7. Middle East & Africa
    • 6.7.1. Overview
    • 6.7.2. Middle East & Africa Atrial Fibrillation Market Estimate by Market Segment
    • 6.7.3. Middle East & Africa Atrial Fibrillation Market Estimate by Country
    • 6.7.4. Middle East
    • 6.7.5. Africa

7 . COMPETITIVE LANDSCAPE OF THE ATRIAL FIBRILLATION COMPANIES

  • 7.1. Atrial Fibrillation Market Competition
  • 7.2. Partnership/Collaboration/Agreement
  • 7.3. Merger And Acquisitions
  • 7.4. New Product Launch
  • 7.5. Other Developments

8 . COMPANY PROFILES OF ATRIAL FIBRILLATION INDUSTRY

  • 8.1. Company Share Analysis
  • 8.2. Market Concentration Rate
  • 8.3. Abbott Laboratories
    • 8.3.1. Company Overview
    • 8.3.2. Financials
    • 8.3.3. Products
    • 8.3.4. Recent Developments
  • 8.4. Atricure, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Financials
    • 8.4.3. Products
    • 8.4.4. Recent Developments
  • 8.5. Biotronik Se & Co. Kg
    • 8.5.1. Company Overview
    • 8.5.2. Financials
    • 8.5.3. Products
    • 8.5.4. Recent Developments
  • 8.6. Boston Scientific Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Financials
    • 8.6.3. Products
    • 8.6.4. Recent Developments
  • 8.7. Johnson & Johnson
    • 8.7.1. Company Overview
    • 8.7.2. Financials
    • 8.7.3. Products
    • 8.7.4. Recent Developments
  • 8.8. Koninklijke Philips N.V.
    • 8.8.1. Company Overview
    • 8.8.2. Financials
    • 8.8.3. Products
    • 8.8.4. Recent Developments
  • 8.9. Medtronic Plc
    • 8.9.1. Company Overview
    • 8.9.2. Financials
    • 8.9.3. Products
    • 8.9.4. Recent Developments
  • 8.10. Microport Scientific Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Financials
    • 8.10.3. Products
    • 8.10.4. Recent Developments
  • 8.11. Siemens Ag
    • 8.11.1. Company Overview
    • 8.11.2. Financials
    • 8.11.3. Products
    • 8.11.4. Recent Developments
  • 8.12. St. Jude Medical Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Financials
    • 8.12.3. Products
    • 8.12.4. Recent Developments

9. IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 9.1. Impact Analysis of Covid-19 Outbreak on the Market
    • 9.1.1. Direct Impact on Production
    • 9.1.2. Supply Chain and Market Disruption
    • 9.1.3. Financial Impact on Firms and Financial Markets
  • 9.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 9.3. Pre V/S Post COVID-19 Market
  • 9.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
  • 9.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦